10-93592193-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006744.4(RBP4):c.569-81T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00953 in 1,208,174 control chromosomes in the GnomAD database, including 613 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.039 ( 360 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 253 hom. )
Consequence
RBP4
NM_006744.4 intron
NM_006744.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.492
Publications
0 publications found
Genes affected
RBP4 (HGNC:9922): (retinol binding protein 4) This protein belongs to the lipocalin family and is the specific carrier for retinol (vitamin A alcohol) in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein posttranslationally and results in defective delivery and supply to the epidermal cells. [provided by RefSeq, Jul 2008]
FFAR4 (HGNC:19061): (free fatty acid receptor 4) This gene encodes a G protein-coupled receptor (GPR) which belongs to the rhodopsin family of GPRs. The encoded protein functions as a receptor for free fatty acids, including omega-3, and participates in suppressing anti-inflammatory responses and insulin sensitizing. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-93592193-A-G is Benign according to our data. Variant chr10-93592193-A-G is described in ClinVar as [Benign]. Clinvar id is 1263116.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.13 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBP4 | NM_006744.4 | c.569-81T>C | intron_variant | Intron 5 of 5 | ENST00000371464.8 | NP_006735.2 | ||
RBP4 | NM_001323517.1 | c.569-81T>C | intron_variant | Intron 5 of 5 | NP_001310446.1 | |||
RBP4 | NM_001323518.2 | c.563-81T>C | intron_variant | Intron 5 of 5 | NP_001310447.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBP4 | ENST00000371464.8 | c.569-81T>C | intron_variant | Intron 5 of 5 | 1 | NM_006744.4 | ENSP00000360519.3 | |||
FFAR4 | ENST00000604414.1 | c.697-11881A>G | intron_variant | Intron 2 of 2 | 3 | ENSP00000474477.1 | ||||
RBP4 | ENST00000371467.5 | c.569-81T>C | intron_variant | Intron 5 of 5 | 5 | ENSP00000360522.1 | ||||
RBP4 | ENST00000371469.2 | c.563-81T>C | intron_variant | Intron 5 of 5 | 5 | ENSP00000360524.2 |
Frequencies
GnomAD3 genomes AF: 0.0395 AC: 6007AN: 152230Hom.: 360 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6007
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00521 AC: 5501AN: 1055826Hom.: 253 AF XY: 0.00455 AC XY: 2478AN XY: 544178 show subpopulations
GnomAD4 exome
AF:
AC:
5501
AN:
1055826
Hom.:
AF XY:
AC XY:
2478
AN XY:
544178
show subpopulations
African (AFR)
AF:
AC:
3512
AN:
25516
American (AMR)
AF:
AC:
463
AN:
43676
Ashkenazi Jewish (ASJ)
AF:
AC:
220
AN:
23514
East Asian (EAS)
AF:
AC:
0
AN:
37736
South Asian (SAS)
AF:
AC:
24
AN:
77654
European-Finnish (FIN)
AF:
AC:
1
AN:
52760
Middle Eastern (MID)
AF:
AC:
71
AN:
5010
European-Non Finnish (NFE)
AF:
AC:
628
AN:
742712
Other (OTH)
AF:
AC:
582
AN:
47248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
265
530
795
1060
1325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0395 AC: 6015AN: 152348Hom.: 360 Cov.: 32 AF XY: 0.0385 AC XY: 2872AN XY: 74514 show subpopulations
GnomAD4 genome
AF:
AC:
6015
AN:
152348
Hom.:
Cov.:
32
AF XY:
AC XY:
2872
AN XY:
74514
show subpopulations
African (AFR)
AF:
AC:
5513
AN:
41556
American (AMR)
AF:
AC:
319
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
37
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5194
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
71
AN:
68042
Other (OTH)
AF:
AC:
69
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
275
551
826
1102
1377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
26
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 25, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.